Certara’s Simcyp COVID-19 Vaccine Model employs biosimulation and computer-generated, virtual populations to facilitate global vaccine decision-making. It addresses important COVID-19 vaccine questions such as optimal dose and timing, whether there are differences in immune response with age and ethnicity and expected duration of antibody response.